First look at new brain drug in healthy people
NCT ID NCT07253272
Summary
This early-stage study tested a single oral dose of a new drug called ENX-104 in 10 healthy volunteers. The main goals were to see if it was safe, how it moved through the body, and how much it attached to specific targets in the brain using PET scans. This type of study helps researchers understand a drug's basic effects before testing it in people with a specific illness.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Parexel London EPCU
London, Middlesex, HA1 3UJ, United Kingdom
Conditions
Explore the condition pages connected to this study.